Universal pharmacare benefits business and working families

The federal government can be on the right side of history as the upcoming election looms. Or, it can offer costly half measures that mostly benefit big pharma and the insurance industries and leave the rest of us out in the cold. The choice is clear.

This is the unfinished business of medicare, as contemplated by Tommy Douglas, right, pictured with Thérèse Casgrain in 1995, the visionary of our cherished health-care system, write Anita Huberman and Hassan Yussuff.Photograph courtesy of Wikimedia Commons

Opinion

BY ANITA HUBERMAN & HASSAN YUSSUFF

February 25, 2019

Every government struggles with how best to support the people it serves. One hopes and assumes that decisions are based on thorough research, meaningful consultations, and with the guidance of experts in the field. So far, the federal government can check off all of these boxes when it comes to ph...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy